Logo | Name | Σ | Employees | ||
---|---|---|---|---|---|
ProductLife Group ProductLife Group’s mission is to improve human health by delivering regulatory compliance services for the safe and effective use of medical solutions. Since almost 30 years, PLG supports clients through the entire product life cycle, combining local expertise with global reach spanning more than 130 countries. It provides consulting and outsourcing services in the areas of regulatory affairs, quality and compliance, vigilances and medical information, covering both established products and innovative therapeutics & diagnostics. With a goal of continuously improving the value delivered to people and customers, PLG is committed to long-term partnership, innovation, flexibility, and cost efficiency. Data Management, … Type: SMB Activities: biotech deeptech healthtech regtech Technologies: A.I. | 9 | 4 | 6 | 1,312 | |
PerformanSe Soft Skills For Good For over 35 years, PerformanSe has been providing behavioural and cognitive skills assessment solutions in the professional environment. As French market leader, its large range of tools and associated services enables PerformanSe to accompany HR professionals in recruitment, talent management, collective efficiency and vocational guidance Pioneer in many fields of on-line assessment, PerformanSe offers you more and more innovative, operational and reliable solutions. PerformanSe’s expertise relies on: - 100% web equipped solutions, available on a secured platform, to manage evaluations in an autonomous way - Personalised service offers, according to your needs (assessment interviews, made-to-measure competency … Type: SMB Activities: hrtech biotech deeptech Technologies: SaaS | 24 | 3 | 20 | 92 | |
ECOCERT Group Act for a sustainable world For over 30 years, ECOCERT has and continues to assist stakeholders in the implementation and promotion of sustainable practices through certification, consulting and training. Implanted in 27 countries, our international subsidiaries allow us to provide global services all over the world. Committed to organic farming since its creation, ECOCERT has now extended its activities to many sectors: agriculture and agri-food, cosmetics, textiles, environment, fair trade, etc. 🎬 Ecocert presentation: https://youtu.be/1JeSe5g3FQw 🎬 Presentación de Ecocert: https://youtu.be/jDKINN4mcRM Type: SMB Activities: biotech cleantech deeptech greentech Technologies: Bio sourced materials | 19 | 6 | 16 | 1,480 | |
Trials.ai by ZS technology that leverages artificial intelligence to optimize clinical trial protocols for speed and success Our tech helps teams design better clinical trials with Ai - because patients don’t have time to wait. Clinical Trials, Medical Device Trials, study design, protocol design, protocol optimization, epidemology, life science, biotech, digital health, pharmaceuticals, pharma, health tech, ai, machine learning, deep learning, and startup Type: Startup Activities: healthtech biotech deeptech Technologies: A.I. A.I. - Deep Learning A.I. - Machine Learning | 3 | 1 | 1 | 2 | |
Bioharmony Therapeutics At Bioharmony Therapeutics, we are developing nontraditional antimicrobial therapeutics by exploiting millions of years of phage-bacteria evolution. Our focus is on targeting infectious diseases caused by multidrug-resistant (MDR) Gram-negative bacteria. Our primary therapeutic indication is for Acinetobacter baumannii skin and wound infections. Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 2 | 0 | 2 | 1 | |
Evofem Biosciences Developing and commercializing products that address unmet needs in women’s sexual and reproductive health. Evofem Biosciences, Inc., (OTCQB: EVFM) is a commercial-stage biopharmaceutical company committed to developing and commercializing innovative products to address unmet needs in women's sexual and reproductive health. In September 2020, Evofem launched Phexxi, the first and only hormone-free, on-demand, prescription birth control available in the U.S. that women use only when they have sex. In July 2024, Evofem acquired SOLOSEC, an FDA-approved single-dose oral antimicrobial agent for the treatment of two common sexual health infections: trichomoniasis and bacterial vaginosis. | 4 | 1 | 2 | 43 | |
Suvoda IRT, eConsent, and eCOA solutions to help you wisely guide novel science through complex clinical trials Suvoda is a global clinical trial technology company that provides IRT, eConsent and eCOA software and services for complex, life-sustaining studies in therapeutic areas like oncology, central nervous system, and rare disease. Clinical trial management, Interactive response technology, Subject randomization, Trial supply management, IWRS, IRT, Interactive Web Response System, Clinical Supplies, Patient Logistics, and Clinical Supply Logistics Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 10 | 1 | 9 | 958 | |
Ryvu Therapeutics Developing novel treatments at the forefront of oncology Ryvu Therapeutics is a clinical-stage drug discovery and development company focused on novel small molecule therapies that address emerging targets in oncology. Internally discovered pipeline candidates make use of diverse therapeutic mechanisms driven by emerging knowledge of cancer biology, including small molecules directed at kinase, synthetic lethality, and immuno-oncology targets. Ryvu’s most advanced programs are RVU120 - a selective CDK8/CDK19 kinase inhibitor with potential for the treatment of hematological malignancies and solid tumors currently in Phase I clinical development for the treatment of acute myeloid leukemia and myelodysplastic syndrome, and Phase I/II … Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 8 | 0 | 8 | 286 | |
Serna Bio Mapping the druggable transcriptome An estimated 85% of the ~3 billion base pairs in the human genome is transcribed into RNA, but only ~1.5% of these code for proteins. While the chemical properties of protein binders are increasingly understood and interrogated, the field of RNA-targeted drugs is relatively new and the properties of small molecules that drive specific and selective targeting of RNA, and associated assays, are yet to be developed. At Serna Bio [previously Ladder Therapeutics] we are using an AI enabled, data-first approach to write the rules that define RNA-small molecule interactions. Our Discovery Platform powers our first-in-class … Type: Startup Activities: biotech deeptech Technologies: A.I. A.I. - Machine Learning Synthetic Biology | 0 | 0 | 0 | 14 | |
RangeMe Where product discovery starts. RangeMe is the leading online product discovery, sourcing, and purchasing platform that helps buyers and suppliers from around the world discover, connect, transact, and grow their businesses with ease. RangeMe enables retail buyers to efficiently discover and purchase products while empowering suppliers to manage, showcase, and grow their brands with the tools, insights, and services they need. Retail Buyers, Baby, Skincare, Beauty, Food, Beverage, Home, Office, Healthcare, Sports, Toys, Games, Suppliers and Manufacturers, and Consumer Goods / Products Type: Startup Activities: healthtech biotech deeptech fashtech games kidtech Technologies: SaaS | 10 | 1 | 6 | 57 | |
Foghorn Therapeutics Inc. Foghorn Therapeutics is pioneering the discovery and development of a new class of medicines targeting genetically determined dependencies within the chromatin regulatory system, an untapped opportunity for therapeutic intervention. Our proprietary Gene Traffic Control® platform gives us an integrated, mechanistic understanding of how the various components of the chromatin regulatory system interact, allowing us to identify, validate and potentially drug targets within the system. Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 3 | 2 | 4 | 126 | |
Paradigm4 The Right Cohorts built from all your multimodal data. Human-in-the-loop ML validation. Find the right druggable targets fast with the REVEAL analytical solutions platform—validated by global pharmas and biotechs. "We’ve discovered insights that we wouldn’t have known without this system. Paradigm4’s platform is the foundation of our target discovery efforts." Website: paradigm4.com Twitter: @paradigm4 LinkedIn: company/paradigm4 Life Sciences Data Management and Elastic Computing, Scalable Analytics, Machine-Learning, Bioinformatics Services, and Allotrope Scientific Data support Type: Startup Activities: biotech deeptech Technologies: A.I. A.I. - Machine Learning Data Analytics IoT | 7 | 0 | 4 | 30 | |
Sio Gene Therapies Pushing the boundaries of gene therapy to develop treatments for debilitating neurodegenerative diseases. Sio Gene Therapies combines cutting-edge science with bold imagination to develop genetic medicines that aim to radically improve the lives of patients. Our current pipeline of clinical-stage candidates includes the first potentially curative AAV-based gene therapies for GM1 gangliosidosis and Tay-Sachs/Sandhoff diseases, which are rare and uniformly fatal pediatric conditions caused by single gene deficiencies. We are also expanding the reach of gene therapy to highly prevalent conditions such as Parkinson’s disease, which affects millions of patients globally. Led by an experienced team of gene therapy development … Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 2 | 1 | 1 | 29 | |
OvaScience OvaScience, Inc. (NASDAQ:OVAS) is a company focused on the discovery and development of new treatment options for women and families struggling with infertility. Each OvaScience treatment is based on the Company’s proprietary technology platform that leverages the breakthrough discovery of EggPC cells – immature egg cells found within the outer ovarian cortex. OvaScience is developing OvaPrime, a potential fertility treatment that could help restore a woman’s egg production, and OvaTure, a potential fertility treatment that eliminates the need for hormone stimulation. OvaScience’s AUGMENT treatment, designed to improve fertilization and pregnancy rates, is available in Japan under an exclusive license to … Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 6 | 0 | 1 | 8 | |
Scene Health Breakthrough medication support for better health. Scene Health (formerly emocha Health) is solving the decades-old problem of medication nonadherence by leveraging the power of people, science, and technology. Our 360° model of care enhances the gold standard of medication adherence, Directly Observed Therapy. Combining personalized video coaching, education, and motivational content, we bring healthcare professionals, patients, and their families together to solve the $500B medication nonadherence problem. Our mobile app allows patients to connect with a care team of pharmacists, nurses, and health coaches through daily video check-ins, anytime and anywhere. We make it fun for patients to stay on … Type: Startup Activities: healthtech deeptech biotech | 10 | 3 | 9 | 69 | |
HueDx Accelerating time-to-market for Rapid, Quantitative, Assay-based (RQA) diagnostic tests HueDx is a Rapid, Quantitative, Assay-based (RQA) test development and launch platform that eliminates the need to develop physical devices and software to launch an RQA product. In doing so, HueDx makes the accessibility of launching flagship or complimentary diagnostics accessible to companies that would not normally consider the undertaking and veterans of the process. Type: Startup Activities: biotech deeptech Technologies: SaaS | 5 | 1 | 5 | 12 | |
InquisitHealth is now Pyx Health Delivering better health 1-1 via an empathy-first Peer workforce Health plans, health systems, and employers leverage our Peer workforce (tech-enabled remote workforce of community health workers) to engage struggling patients (with empathy!) and help them address SDoH barriers, activate healthy behaviors and improve clinical outcomes. peer support, peer mentoring, community health workers, diabetes, asthma, prediabetes, sickle cell, hypertension, digital health, and coaching Type: Startup Activities: healthtech biotech deeptech Technologies: Synthetic Biology | 1 | 1 | 0 | 37 | |
Synthorx Inc Synthorx, Inc. is a biotechnology company focused on prolonging and improving the lives of people with cancer and autoimmune disorders. Synthorx’s proprietary, first-of-its-kind Expanded Genetic Alphabet platform technology expands the genetic code by adding a new DNA base pair and is designed to create optimized biologics, referred to as Synthorins. A Synthorin is a protein optimized through incorporation of novel amino acids encoded by the new DNA base pair that enables site-specific modifications, which enhance the pharmacological properties of these therapeutics. The company’s lead product candidate, THOR-707, a variant of IL-2, is in development in multiple tumor types as a … Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 2 | 2 | 0 | 9 | |
AssistRx Specialty therapy initiation and patient support company delivering informed access and improved outcomes. AssistRx has engineered the perfect blend of technology and talent to provide life sciences organizations with an advanced therapy initiation and patient support solution that improves patient uptake, visibility and outcomes. Our balanced approach streamlines enrollment, reduces therapy disruptions and provides real-time therapy visibility through an integrated solution—delivering the informed touchpoints that simplify a complex system to enable better results for today’s patients. The AssistRx solution includes therapy initiation and patient support, patient education and adherence, and therapy insights and analytics. We have built our entire platform … Type: Startup Activities: biotech deeptech it services Technologies: Data Analytics | 7 | 0 | 6 | 731 | |
Kinnos Pioneering color technology to revolutionize how we use disinfectants. Kinnos is a New York-based company that is pioneering color technology to revolutionize how we use disinfectants. Our flagship product, Highlight, is a patented and award-winning technology used by first responders, healthcare systems, and transit agencies to radically improve disinfection technique and quality. | 4 | 1 | 2 | 20 | |
Elaniti Your blueprint for healthy soil. At Elaniti (elaniti.com) we provide key decision making information, enabling growers and organisations to achieve optimal crop outcomes by improving their soil health. Utilizing applied machine learning, we are developing proprietary statistical models that predict key crop outcomes based on soil biology, physico-chemistry and nutrient composition. We are looking for some early hires. Please reach out if you have an interest in improving soil health, on-farm outcomes, and food security. Type: Startup Activities: agritech biotech healthtech Technologies: A.I. | 1 | 0 | 1 | 2 | |
Biome Makers Inc. Decoding soil biology: Actionable soil intelligence for better agronomic decisions. Founded in California’s Silicon Valley in 2015, Biome Makers is one of the foremost global AgTech leaders, setting the standard in soil health with BeCrop® technology, the largest global taxonomic database of 24M microorganisms. Built on industry-leading AgTech expertise and driven by data and science, Biome Makers connect soil biology to agricultural decision-making to optimize farming practices and reverse the degradation of arable soils. With labs across the globe, customers on 6 continents, and 1M+ acres of land impacted, Biome Makers revitalizes soil functionality and agricultural sustainability worldwide. Type: Startup Activities: agritech biotech deeptech Technologies: Data Analytics | 11 | 5 | 7 | 84 | |
Genialis The RNA Biomarker Company. Genialis, the RNA biomarker company, is creating a world where healthcare delivers the best possible outcomes for patients, their families, and their communities. Genialis develops and validates clinically actionable biomarkers informed by the world’s most ethnographically diverse cancer data sets to better predict patient responses and guide treatment decisions for targeted inhibitors, immunotherapies, and other emerging therapeutic classes. Genialis is trusted by pharma and diagnostics partners, and together, we are transforming medicine through data. Data Fusion, Machine Learning, Biomedical Data Analysis, Omics Data Integration, Precision Medicine, Software Development, Data Visualization, Gene Signature, and Predictive Biomarker Type: Startup Activities: biotech deeptech Technologies: A.I. A.I. - Machine Learning Data Analytics | 16 | 0 | 15 | 41 | |
Keel Labs Our mission is to harness the radical potential of our oceans to transform the textile industry and the world. Keel LabsTM began in 2017 as AlgiKnit, creating ocean-focused materials built from renewable resources. In 2022, Keel Labs was established as a platform for innovation, broadening our vision for the potential of the ocean to accelerate our planet’s development towards a more sustainable future. Driven by the exploration of novel resources from the ocean, Keel LabsTM functions as a hub for the next generation of climate-focused solutions derived from nature. So, though our name has changed, our mission remains the same: … Type: Startup Activities: biotech deeptech cleantech greentech Technologies: Bio sourced materials New Materials | 2 | 1 | 0 | 31 | |
Institut de la Vision [Automatic translation follows] From the movement of knowledge to the therapeutic approaches of tomorrow Built in the heart of the Hôpital national des 15-20, the Vision Institute is one of the largest integrated research centers on vision diseases in Europe. Designed as a place of gathering and exchange, it brings together on the same site fundamental, clinical and industrial research, thus promoting the sharing of concepts and techniques, the meeting of complementary skills and expertise and the emergence of new avenues of research. Researchers, doctors and industrialists work together to discover and validate new therapies, preventive solutions, as well as … Type: NGO, Think-tanks, Ed, & Culture Activities: biotech deeptech healthtech | 23 | 8 | 10 | 227 | |
ARCAGY-GINECO [Automatic translation follows] Coordinates international clinical trials in the field of gynecologic and metastatic breast cancers. Arcagy-Gineco is a cooperative group founded in 1993 and specialized in clinical research in the field of women's cancers (gynecologic and metastatic breast cancers). Its objective is to improve the survival and quality of life of patients with gynecologic or metastatic breast cancer by setting up and coordinating therapeutic trials in France and internationally. Arcagy-Gineco brings together medical and scientific expertise in the field of gynecologic oncology and metastatic breast cancer, which gives it a unique capacity to successfully conduct clinical research in the … Type: NGO, Think-tanks, Ed, & Culture Activities: biotech deeptech healthtech | 1 | 0 | 1 | 36 | |
Ripack - Groupe Sefmat La Protection par Excellence In 1922, RIPPES begins its activity by producing flame welding equipment. In 1975 the idea of covering a loaded pallet with a heat shrink cover in order to stabilise the load and offer weather and theft protection, was hatched and rapidly expanded. The RIPPES Company was one of the first to develop a 'gun' connected to a gas supply, which, by dint of its hot flame, shrunk these shrink wrap covers. The rapid expansion of demand for these shrink 'guns' led to the company setting up a new corporate entity in 1981; the SEFMAT company, with … Type: SMB Activities: biotech deeptech manufacturing | 1 | 1 | 0 | 15 | |
Suomen Punainen Risti, Veripalvelu [Automatic translation follows] The Blood Service of the Finnish Red Cross produces safe and effective blood products and laboratory services for hospitals needed in the treatment of patients. We take care of collecting blood from voluntary blood donors in accordance with the needs of patient care. We also offer hospitals services that support stem cell and organ transplants. The blood service is a non-profit organization. Our annual budget is approximately 60 million. EUR and we employ about 500 people. We are part of a unique helping chain with donors and healthcare staff. blood products, laboratory services, stem cell and tissue … Type: SMB Activities: deeptech healthtech biotech Technologies: Synthetic Biology | 1 | 1 | 0 | 202 | |
Liminal BioSciences Liminal BioSciences is a development-stage biopharmaceutical company focused on the discovery and development of novel distinctive small molecule therapeutics that modulate G protein-coupled receptor (GPCR) pathways. The company is developing new proprietary small molecule therapeutic candidates with the intention of developing best-in-class therapeutics for the treatment of unmet metabolic, inflammatory and fibrotic diseases, using its integrated drug discovery platform, expertise in medicinal chemistry and deep understanding of GPCR biology. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. See our social media community guidelines at https://liminalbiosciences.com/social-media-community-guidelines/ Type: SMB Activities: biotech deeptech healthtech Technologies: Synthetic Biology | 1 | 0 | 1 | 29 | |
Kuur Therapeutics Kuur is committed to transforming the lives of patients with cancer and is leading the development of off-the-shelf engineered CAR-NKT cell therapies. Our approach combines the highly differentiated, natural biology of a specific subset of T cells, called natural killer T cells (NKT cells) and innovative chimeric antigen receptor (CAR) construct engineering. In combination, this delivers a very compelling and unique platform, that we believe has the potential to produce many future therapies targeting both hematological and solid tumors. Immunotherapy, Cancer, Oncology, T cells, TCR, CAR, CAR-NKT, clinical trial, NKT Cells, celltherapy, and lifesciences Type: SMB Activities: biotech deeptech transporttech Technologies: Synthetic Biology | 2 | 2 | 0 | 91 | |
Calysta Protein without limits Calysta is a world leader in cellular agriculture, creating protein without limits via a patented fermentation platform that uses no arable land, plant or animal products. As the world’s demand for healthy, sustainably produced food continues to grow, Calysta’s family of ingredients – FeedKind, FeedKind Net Zero, and Positive Protein – are ready to meet the challenge. Powered by renewable energy, Calysta’s protein products can preserve biodiversity and contribute to improving the global nexus of water, energy and food security. Aquaculture, Industrial Biotechnology, Fish and Livestock Feed, Food & Energy Security, Sustainable Products, Biological Gas to Liquids, … Type: Startup Activities: biotech deeptech Technologies: Bio sourced materials | 7 | 2 | 5 | 77 | |
REGENXBIO Seeking to improve lives through the curative potential of gene therapy. REGENXBIO is a leading clinical-stage biotechnology company seeking to improve lives through the curative potential of gene therapy. Since its founding in 2009, REGENXBIO has pioneered the development of AAV Therapeutics, an innovative class of gene therapy medicines. REGENXBIO is advancing a pipeline of AAV Therapeutics for retinal and rare diseases, including ABBV-RGX-314 for the treatment of wet AMD and diabetic retinopathy, being developed in collaboration with AbbVie, RGX-202 for the treatment of Duchenne and RGX-121 for the treatment of MPS II. Thousands of patients have been treated with … Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology SaaS | 1 | 1 | 0 | 363 | |
Sage Therapeutics Our mission is to pioneer solutions to deliver life-changing brain health medicines, so every person can thrive. Sage Therapeutics is a biopharmaceutical company committed to developing novel therapies with the potential to transform the lives of people with debilitating disorders of the brain. We are pursuing new pathways with the goal of improving brain health and change how brain disorders are thought about and treated. Our mission is to pioneer solutions with the potential to deliver life-changing brain health medicines, so every person can thrive. Welcome To The Workplace With A Difference At Sage, we believe that life is more … Type: Startup Activities: healthtech biotech deeptech Technologies: Synthetic Biology | 8 | 2 | 4 | 621 | |
Aimmune Therapeutics POWER OVER FOOD ALLERGIES Aimmune Therapeutics, Inc., a Nestlé Health Science Company, is a biopharmaceutical company developing and commercializing treatments for potentially life-threatening food allergies. With a mission to improve the lives of people with food allergies, Aimmune is developing and commercializing oral treatments for potentially life-threatening food allergies. The Company’s Characterized Oral Desensitization ImmunoTherapy (CODITTM) approach is intended to provide meaningful levels of protection against allergic reactions resulting from accidental exposure to food allergens by desensitizing patients with defined, precise amounts of key allergens. Aimmune has one FDA-approved medicine for peanut allergy and other investigational therapies in development to … Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 1 | 1 | 0 | 118 | |
Precision Diagnostics Ensuring every patient, provider, and payor benefits from our services. Precision Diagnostics is the only U.S. laboratory to have invested in and committed to deploying the most advanced, ultra-high sensitivity LC-MS/MS technology for clinical urine and oral fluid drug testing. Our accredited laboratory’s automated processes virtually eliminate human error, ensure fast turnaround times, and permit our scientists to focus on the data that merit their attention. Our testing methodology gives clinicians a better possibility of ensuring patient compliance and improving outcomes. We provide world-class client support and an analytics platform which delivers actionable data in a format that supports clinical … Type: Startup Activities: healthtech biotech deeptech Technologies: Data Analytics | 1 | 0 | 1 | 237 | |
Candid Your digital platform for oral healthcare. ✨ At Candid, we believe dental professionals and their patients deserve more than what other clear aligner systems provide. That’s why we created CandidProTM: a total orthodontic solution that brings clinical support, connected treatment technology, and high-touch service into any practice. Health/Beauty, Cosmetic Dentistry, Cosmetics, Smile, Teeth , Orthodontics, and Clear Aligners Type: Startup Activities: biotech deeptech retail Technologies: SaaS | 1 | 1 | 0 | 327 | |
HealthFactors, Inc. Smart therapy management improves clinical outcomes, makes data actionable, and improves care delivery. Health Factors, a medical technology company located in Minneapolis, is harnessing the power of Smart Therapy Management to change how respiratory care is delivered and to improve the patient and caregiver experience. Our core competencies include Medical Device Commercialization, Digital Health Solutions, and Therapeutic Transformation – all of which can be leveraged individually as service offerings to our industry partners or blended to create a Smart Therapy Management approach. Smart Therapy Management allows us to work efficiently in a value-based care arrangement to address unmet needs and … Type: Startup Activities: healthtech deeptech biotech Technologies: IoT | 0 | 0 | 0 | 4 | |
Boston Center for Memory Boston Center for Memory is an independent multi-specialty diagnostic and treatment center. The Boston Center for Memory provides evaluations of the highest quality for patients who have concerns about their memory in a timely manner, access to the latest treatments through participation in clinical trials, and support for the development of new treatments for Alzheimer’s disease and other causes of memory loss. Alzheimer's disease and Clinical Trials | 0 | 0 | 0 | 15 | |
Recursion Decoding Biology to Radically Improve Lives We are a clinical-stage TechBio company decoding biology by integrating technological innovations across biology, chemistry, automation, data science and engineering to industrialize drug discovery. We are leveraging new technology to create virtuous cycles of learning around datasets to build the next-generation biopharmaceutical company. It’s complex biology, decoded. While we are united in a common mission, Decoding Biology to Radically Improve Lives, our greatest strength lies in our differences: expertise, gender, race, disciplines, experience, and perspectives. Deliberately building and cultivating this culture is critical to achieving our audacious goals. We are proudly headquartered in Salt … Type: Startup Activities: biotech deeptech Technologies: A.I. A.I. - Machine Learning Synthetic Biology | 24 | 4 | 20 | 602 | |
CareSignal® – Lightbeam's Deviceless Remote Patient Monitoring Deviceless Remote Patient Monitoring®: Scalable, evidence-based approach for improving clinical and financial outcomes. Lightbeam’s Deviceless Remote Patient Monitoring (RPM) solution, CareSignal, helps healthcare organizations and payers scale care management, touch more lives, and keep patients engaged. Self-guided Demo: https://try.caresignal.health Learn More: https://lightbeamhealth.com/deviceless-remote-patient-monitoring/ Self-guided Demo: https://try.caresignal.health Learn More: https://www.caresignal.health CareSignal's founding employees include: Blake Marggraff, Evan Huang, Joe McDonald, Jason Roche, and Emily Srygley. Mobile Health, Value-Based Care, Remote Patient Monitoring, Patient Engagement, Population Health, Chronic Disease Management, Deviceless Remote Patient Monitoring, Behavioral Health, Accountable Care Organizations, Medicare Advantage, Care Coordination, Medicaid, Payers, Provider Organizations, Health Equity, Social Determinants of Health, … Type: Startup Activities: healthtech biotech deeptech | 1 | 0 | 0 | 28 | |
DNAsimple DNAsimple allows patients or anyone to contribute to scientific studies and provides a much-needed service for genomics labs - the opportunity to find study participants and obtain their DNA samples from various demographics for the purpose of their research studies. Through DNAsimple, scientists have a ready access to samples and sample donors get compensated for their study participation. genetics, genomics, biobanking, genetic research, saliva , DNA, DNA sample, microbiome, donor compensation, DNAsimple, healthcare research, and personalized medicine | 3 | 1 | 2 | 7 | |
Elysium Health The company that believes everyone should benefit directly from compelling scientific research. Elysium Health’s mission is to solve the biggest challenges in health with science, to help people live healthier for longer. Elysium works directly with top scientists, clinicians and health professionals around the world to translate advances in science and technology into innovative health products that work. Our product development pipeline begins with research and development, continues with preclinical studies, and culminates with human clinical trials to demonstrate the safety and efficacy of products. Throughout this process, Elysium’s focus is to develop compounds found in nature that allow people … | 1 | 1 | 0 | 82 | |
Verastem Oncology Verastem Oncology (Nasdaq: VSTM) (Verastem, Inc.) is a late-stage development biopharmaceutical company committed to the development and commercialization of new medicines to improve the lives of patients diagnosed with cancer. Our pipeline is focused on novel small molecule drugs that inhibit critical signaling pathways in cancer that promote cancer cell survival and tumor growth, including RAF/MEK inhibition and FAK inhibition. Pursuing unexplored pathways demands that we’re purposeful in everything we do. And it’s an endeavor that’s only possible with an experienced team of employees and partners dedicated to a singular purpose: changing and improving the way cancer is treated by … Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 3 | 1 | 2 | 104 | |
Varian At Varian, a Siemens Healthineers company, we envision a world without fear of cancer. At Varian, a Siemens Healthineers company, we envision a world without fear of cancer. For more than 75 years, Varian has developed, built, and delivered innovative technologies and solutions that help care providers around the globe treat millions of patients each year. Today, as a Siemens Healthineers company, we support every step of the cancer care journey – from screening to survivorship. From advanced imaging and radiation therapy, to comprehensive software and services, to interventional radiology, we are harnessing the power of our perspective while also … Type: Startup Activities: biotech healthtech deeptech sporttech Technologies: SaaS | 1 | 1 | 0 | 9,807 | |
Lyfebulb Connect People. Inspire Change. Impact Lives. Lyfebulb is a chronic disease focused, patient empowerment platform that connects patients, industry and investors to support user-driven innovation. Health, Diabetes, Chronic Disease, Wellness, Investing, Finance, Cancer, Inflammatory Bowel Disease, Entrepreneurship, and Chronic Illness Type: Startup Activities: healthtech deeptech biotech entrepreneurship fintech Technologies: SaaS | 8 | 2 | 7 | 15 | |
Lygos Better materials for better products Lygos is a pioneering sustainable specialty chemicals company, leading the world’s transition toward better, cleaner, and more sustainable products. We have built a proprietary and fully integrated platform of the most advanced technologies across synthetic biology, industrial chemistry, and application development to rapidly deliver market relevant solutions to some of the world’s biggest sustainability challenges. With a pipeline of high-performing, innovative solutions, Lygos is paving the way for generations of new sustainable solutions for our world. Synthetic Biology and Specialty Chemicals Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 1 | 0 | 1 | 87 | |
Aris MD Inc. We are an immersive reality company taking augmented and virtual reality technology and enhancing surgery with it. We are using diagnostic images (MRI, CT, Xray, Ultrasound) and overlaying them over you, the patient during surgery. This gives the surgeon a guided map of your anatomy and your pathology or injury. This shows the surgeon where to cut and more importantly, where not to cut. Every persons anatomy differs not just on the outside but on the inside as well. My heart and liver are not located exactly where your heart and liver are. The surgeon has a general idea of … Type: Startup Activities: biotech deeptech edtech healthtech Technologies: VR | 9 | 1 | 6 | 4 | |
LifeNome Inc. Precision Health and Genomics AI Platform LifeNome is a precision (biology-personalized) health platform powered by Genomics AI (c). We leverage systems-biology, multi-omics, and proprietary artificial intelligence to personalize health and wellbeing services and products of healthcare, insurance, pharmaceutical, nutrition, and fitness organizations worldwide. Our focus areas include precision preventive health (disease screening and intervention design), precision maternal and family health, and precision nutrition, and wellbeing. Awards and Recognitions: - LG Select 10 ($2 Million) - PEPSICO $100K Top Prize Food Tech Accelerator - Best Enterprise Precision Health and Wellness Platform (Biotech Awards, 2021) - Top Personalized Health Startup (Lux Research, … Type: Startup Activities: deeptech biotech Technologies: A.I. | 15 | 2 | 14 | 15 | |
Apic Bio, Inc. Committed to finding cures for patients with genetic diseases Apic Bio is committed to finding cures for patients with genetic diseases. | 1 | 1 | 0 | 6 | |
Roivant Sciences Roivant aims to improve health by rapidly delivering innovative medicines and technologies to patients. We do this by building Vants – nimble, entrepreneurial biotech and healthcare technology companies with a unique approach to sourcing talent, aligning incentives, and deploying technology. The therapies in development across our family of companies target a wide range of diseases including uterine fibroids, endometriosis, prostate cancer, Parkinson’s disease, diabetes, pulmonary arterial hypertension, and multiple rare and fatal pediatric conditions. We focus on disease areas where the magnitude of R&D investment from industry is disproportionately low relative to societal medical needs. In addition to our biopharmaceutical … | 10 | 6 | 3 | 247 | |
Kernel Better data. Better brains. Enabling precision neuromedicine. Kernel's category-defining neuroimaging platform can be used to accelerate treatment development, improve patient outcomes, and reduce healthcare costs. Type: Startup Activities: biotech deeptech Technologies: Data Analytics | 7 | 2 | 1 | 54 | |
Virta Health Virta is the leader in diabetes reversal and sustainable weight loss with a nutrition first approach. We offer a proven, personalized nutrition program and expert support through technology to solve the health epidemic of our generation: diabetes and obesity. Virta empowers members with the tools and knowledge to sustain changes for a longer, healthier life. If you’re ready to transform lives and reinvent the standard of care, join us at Virta! We have opportunities for software engineers, health coaches, scientists, clinicians, and more. Visit https://www.virtahealth.com/careers to see our full list of open roles. See how Virta is transforming healthcare by … Type: Startup Activities: healthtech biotech deeptech Technologies: SaaS | 10 | 1 | 4 | 577 | |
Portable Genomics, Inc. Portable Genomics Inc., La Jolla, CA, was created by Patrick Merel, PhD and a group of molecular biologists from Bordeaux, France, to design a mobile software platform for the use of genome data in personalized, predictive, preventive and participative medicine applications (P4TMMedicine). What makes Portable Genomics unique in the genomics space is a consumer-based approach to the visualization of genomic data. Portable Genomics platform, and IP, uses the digital music data structure to re-organise a genome data set and allows professionals and consumers to simply browse a genome in any MP3-compatible device from iPodsTM to mobile phones, from iWatchTM to … Type: Startup Activities: deeptech biotech Technologies: Data Analytics | 0 | 0 | 0 | 1 | |
EpigenCare Advancing Consumer Epigenetics EpigenCare is a privately held personal epigenomics and digital biotechnology company based in New York. The company offers a direct-to-consumer epigenetics test to assess the dynamic state of one's skin type and quality. Subsequently, capture of the dynamic quality allows for actionable results from the analysis report such that optimized product options are recommended to the consumer. skincare, blockchain, epigenetics, and personal genomics Type: Startup Activities: biotech deeptech Technologies: Blockchain/Cryptocurrency | 2 | 1 | 1 | 2 | |
ApexQubit ApexQubit is a biotechnology company that is harnessing frontier technologies for better health for humanity. ApexQubit is a biotechnology company that is harnessing frontier technologies for discovery of new medicines and better health for humanity. https://www.apexqubit.com/ #ArtificialIntelligence #BioTech #DeepTech #QuantumComputing #FrontierTech #B2B #Startup #RNA #DrugDesign #HealthTech Artificial Intelligence, Quantum Computing, Quantum Machine Learning, DeepTech, FrontierTech, BioTech, and Therapeutics Type: Startup Activities: biotech deeptech Technologies: A.I. A.I. - Machine Learning | 0 | 0 | 0 | 2 | |
Decomer Technology We are developing a novel plant-based water-soluble and edible packaging material as well as products thereof Decomer Technology is developing a novel water-soluble and edible packaging material as well as products thereof. The material is plant-based, tasteless, transparent and hypoallergenic and can be used in food-, detergent-, pharmaceutical-, agricultural and other industries. We combine convenience and sustainability. Type: Startup Activities: agritech biotech deeptech Technologies: Bio sourced materials | 1 | 1 | 0 | 2 | |
Elixirgen Scientific Transform how you model human biology. Elixirgen Scientific is a global leader in regenerative medicine and biotechnology, headquartered in the Science + Technology Park at the Johns Hopkins Medical Campus in Baltimore, MD. Our mission is to advance science and medicine with fast, functional, and scalable induced pluripotent stem cell (iPSC) differentiation products and services. Our state-of-the-art, transcription-factor-based technology allows you to overcome the high cost and inefficiencies associated with lengthy cell differentiation periods. We empower research institutions, pharmaceutical organizations, and biomedical enterprises worldwide, even those with no previous iPSC experience, by increasing access to relevant cells for modeling human … Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 1 | 1 | 0 | 20 | |
Human Longevity, Inc. Live a healthier, longer life. Human Longevity, Inc. TM (HLI) is the genomics-based, health intelligence company creating the world’s largest and most comprehensive database of whole genome, phenotype and clinical data. HLI is developing and applying large scale computing and machine learning to make novel discoveries from these data to generate personalized health insights. Our goal is to extend healthy human life by revolutionizing human health and transforming the practice of medicine. Our DNA determines so much about each of us, but other factors can also influence our health. HLI is focused on compiling and analyzing more genotypic and phenotypic … Type: Startup Activities: biotech deeptech Technologies: A.I. A.I. - Machine Learning | 6 | 4 | 1 | 88 | |
MyoKardia Driven by the heart We officially combined with Bristol Myers Squibb to further strengthen our scientific capabilities and treatments for cardiovascular patients. Visit www.bms.com to learn more about our work to produce the next generation of medicines for patients with serious cardiovascular disease. For more information on the acquisition, see our press release at: https://one.bms.com/40FsT7W Genetic Heart Disease, Cardiomyopathy, biotechnology, cardiovascular disease, heart failure, precision medicine, therapeutics, drug discovery, drug development, and R&D Type: Startup Activities: healthtech biotech deeptech Technologies: Synthetic Biology | 1 | 0 | 1 | 42 | |
Geltor Geltor is the biodesign company powering the products of the future with effective, sustainable, animal-free proteins Geltor is the biodesign company that audaciously imagines and deeply explores all the possibilities that the tree of life has to offer. With customer benefit at the fore of each step of the creative process, Geltor has created the largest selection of designer proteins that are crafted with unparalleled biocompatibility and functionality. These proteins are 100% animal- and GMO-free, globally scalable, and sustainably cultivated. Geltor’s products are the result of endless curiosity and ceaseless optimization, clinically demonstrated for high performance. Biotechnology, Protein, Cosmetics, Personal … Type: Startup Activities: deeptech biotech healthtech fashtech Technologies: Synthetic Biology | 4 | 1 | 2 | 25 | |
DIANA Biotechnologies DIANA Biotechnologies: Diversified Biotech We are leading Czech biotechnology company with a great innovative potential. We focus on the development of products based on our cutting edge research in the fields of molecular diagnostics and drug discovery. We have global ambitions and since our foundation in 2018 we already have achieved some of our goals. During COVID-19 pandemics, we were able to quickly develop one of the most innovative COVID-19 tests worldwide and we helped to increase the testing capacity of the whole country. As a result, we became the biggest Czech manufacturer of RT-PCR tests. Besides RT-PCR, we continue … Type: Startup Activities: biotech deeptech manufacturing Technologies: Synthetic Biology | 3 | 0 | 3 | 61 | |
TriviumVet Bridging the treatment gaps in veterinary care for companion animals TriviumVet are an animal therapeutics company headquartered in Waterford, Ireland. We work with human healthcare and pharmaceutical businesses to bring healthcare applications to the veterinary market including: - veterinary pharmaceuticals, - veterinary medical devices and - veterinary diagnostic solutions Our pipeline includes patented, proprietary technology and pharmaceuticals that are completing European Medical Agency and Food and Drug Administration regulatory pathways. We develop in house research but also work with leading human healthcare companies. You can follow us online @triviumvet on Facebook, Twitter and Linkedin veterinary, pharmaceuticals, research and development, innovation, … Type: Startup Activities: pettech biotech deeptech healthtech Technologies: Synthetic Biology | 10 | 1 | 4 | 15 | |
SNIPR Biome - A CRISPR Company Clinical CRISPR and Gene Therapy of the Microbiome Company We are the CRISPR and Gene Therapy of the Microbiome company! Precision killing of bacteria has the impact to revolutionise the management of untreatable and difficult-to-treat infections as well as complex diseases directly impacted by the human microbiota. Our mission is to develop CRISPR-based medicines that give hope for effective and safe treatment of difficult-to-treat diseases in the future. Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 3 | 0 | 3 | 42 | |
Galecto, Inc. Clinical stage fibrosis and cancer treatments Galecto is a clinical stage biotechnology company committed to the development of novel small molecule therapeutics directed at biological targets which are at the heart of fibrosis, inflammation, and cancer. Galecto was founded by leading fibrosis-focused scientists and biotech executives and is built on more than 10 years of research into galectin and fibrosis modulators. Our team has developed a deep understanding of the galectin family of proteins and the LOXL2 enzyme, and how both influence multiple biological pathways of these complex, often devastating, diseases. Galecto is funded by Novo Holdings, OrbiMed, Ysios, HBM … Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 6 | 1 | 3 | 21 | |
Dante Genomics The genome information company, specialist in whole genome sequencing and interpretation. Owner of Dante Labs. Dante Genomics is a leading global genomics and precision medicine company working to deliver better healthcare and save lives with a more human approach to health. We work with customers across 97 countries and we create customized genomic analysis processes that have an impact on people’s lives. Our mission is to accelerate science for the people. We leverage genome sequencing technology and interpretation so that everyone can make informed decisions about their health and their future. We use the proprietary genomic platform, based on artificial … Type: Startup Activities: biotech deeptech Technologies: A.I. A.I. - Machine Learning | 7 | 1 | 4 | 102 | |
Archer (part of Integrated DNA Technologies) In December 2022, Integrated DNA Technologies, Inc. (IDT) announced the acquisition of ArcherTM. The integration of IDT’s portfolio with the acquired NGS research assays—powered by Anchored Multiplex PCR (AMPTM) technology, which has been foundational in researching novel cancer fusions—will empower labs with an all-in-one solution to uncover biomarkers and advance cancer discoveries. The transaction enables IDT to expand its existing operations, build upon the legacy Archer portfolio, and welcome more than 100 new associates globally. For the latest on IDT, follow their LinkedIn page here: https://www.linkedin.com/company/integrated-dna-technologies next-generation sequencing, cancer research, ngs assays, and DNA sequencing assays | 4 | 0 | 4 | 31 | |
Absci Creating Drugs at the Speed of Ai Absci is a generative AI drug creation company that combines AI with scalable wet lab technologies to create better biologics for patients, faster. Our Integrated Drug CreationTM platform unlocks the potential to accelerate time to clinic and increase the probability of success by simultaneously optimizing multiple drug characteristics important to both development and therapeutic benefit. With the data to learn, the AI to create, and the wet lab to validate, we can screen billions of cells per week, allowing us to go from AI-designed antibodies to wet lab-validated candidates in as little as … Type: Startup Activities: biotech deeptech Technologies: A.I. A.I. - Deep Learning Generative A.I. Synthetic Biology | 10 | 0 | 9 | 184 | |
Zimitech, Inc. Zimitech is a biotechnology company working on creating sugars with functional benefits for healthier lives. | 0 | 0 | 0 | 34 | |
InSyBio A disruptor to Precision Medicine & Nutrition through effective personalization tests empowered with machine-learning InSyBio is a biotechnology pioneer company (www.insybio.com) in personalized healthcare and nutrition which focuses on developing computational frameworks and tools for the analysis of complex life-science and biological data. The key objective of our analysis lies in discovering predictive integrated biosignatures (biomarkers of various categories) and models with increased prognostic and diagnostic aspects for personalized Healthcare and Nutrition Industries. InSyBio has recently expanded its offering including a complete set of services that allows the personalization of nutrition, nutraceutical, vitamin and probiotic products. These services are built … Type: Startup Activities: deeptech biotech Technologies: Data Analytics A.I. - Machine Learning | 1 | 1 | 0 | 6 | |
Wysa Global leader in AI-driven mental health support, NHS (ORCHA) certified, FDA Breakthrough Device Designation. Wysa is an AI-enabled Coach for mental and emotional wellness. Launched in 2016, Wysa provides early intervention via it's AI chatbot, library of evidence-based self-help tools, and messaging-based support from human coaches. Anonymous, empathetic and available 24x7, Wysa covers 11 million lives, and has helped over 6 million people in 95 countries through 500+ million conversations. Wysa is a global leader in digital mental health, rated 93% by ORCHA, the digital health app evaluation agency used by the NHS, with a 100% on clinical assurance; and … Type: Startup Activities: healthtech biotech deeptech Technologies: A.I. A.I. - Natural Language Processing Generative A.I. | 14 | 0 | 10 | 156 | |
Apeel Developing science-backed, technology-supported solutions that help improve the produce experience on shelf. Apeel's evolving technology stack is built on an unprecedented understanding of produce quality and shelf life. This has only deepened as the use of data and technology have given partners a powerful way to accurately and efficiently evaluate produce for ripeness, freshness, and other attributes. Apeel is developing science-backed, technology-supported solutions that help improve the produce experience on shelf. Sustainable Technologies, Crops, Food, Agricultural Services, Environment, Organic, and Biotechnology Type: Startup Activities: biotech deeptech cleantech agritech greentech Technologies: Bio sourced materials | 4 | 2 | 2 | 266 | |
NanOlogy Advancing Intratumoral Drug Therapy Approach: Clinical interest in intratumoral therapy is increasing because of advancements in interventional oncology and growing recognition of the importance of treating the primary tumor across the disease spectrum. Clinical trials are underway by NanOlogy in multiple therapeutic areas to evaluate local delivery of concentrated, sustained chemotherapies to increase solid tumor response, eliminate toxicities associated with systemic agents, and promote favorable immunomodulation. Technology: The NanOlogy commercial scale GMP production platform precipitates dissolved drug substances with sonication and compressed supercritical carbon dioxide to form stable large surface area microparticles (LSAMs) of pure drug containing no excipients or … Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology | 1 | 1 | 1 | 9 | |
Impel Pharmaceuticals Developing life-changing, innovative therapies for diseases with unmet needs Impel Pharmaceuticals is focused on developing and providing transformative therapies for people suffering from diseases with high unmet needs across various disease areas in addition to the central nervous system (CNS), through the pioneering of an optimized approach to drug delivery. We offer and develop treatments that pair the Company’s proprietary Precision Olfactory Delivery (POD®) technology with well-established therapeutics. Intranasal Drug Delivery, Migraine, Parkinson's Disease, CNS Therapeutics, and Autism Type: Startup Activities: healthtech deeptech biotech Technologies: Synthetic Biology | 1 | 1 | 1 | 51 | |
One Codex Fast and easy to use microbiome analysis with the leading microbial reference database One Codex is the leading bioinformatics platform for microbial genomics, supporting taxonomic and functional analysis of metagenomic (WGS), 16S, and other sequencing data. We specialize in creating robust, scalable, and secure bioinformatics solutions for metagenomics and microbial genomics, with a strong focus on ease of use. Founded in 2014, the One Codex platform counts thousands of users across leading academic institutions, biotechnology companies, and public sector organizations. One Codex is built on top of Amazon Web Services and is the only microbial genomics offering providing HIPAA-level security, … Type: Startup Activities: deeptech biotech Technologies: Cybersecurity | 1 | 1 | 0 | 11 | |
Viridian Therapeutics, Inc. Framing the future of autoimmune diseases Viridian is a biopharmaceutical company focused on engineering and developing potential best-in-class medicines for patients with serious and rare diseases. Viridian’s expertise in antibody discovery and protein engineering enables the development of differentiated therapeutic candidates for previously validated drug targets in commercially established disease areas. Viridian is advancing multiple candidates in the clinic for the treatment of patients with thyroid eye disease (TED). The company is conducting two global Phase 3 clinical trials (THRIVE and THRIVE-2) to evaluate the safety and efficacy of VRDN-001 in patients with active and chronic TED. Viridian’s goal is … Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology | 2 | 1 | 2 | 158 | |
Elektrofi Formulating the Future of BiologicsTM Elektrofi is a biopharmaceutical formulation technology company that is revolutionizing the delivery of biologic therapies by giving patients the ability to control how they want to receive and benefit from life-changing medicines. Our breakthrough hyper concentration microparticle technology platform, HyperconTM, resolves the limitations associated with intravenously delivered biologic therapies by enabling convenient at-home subcutaneous self-administration. With a focus on monoclonal antibodies, therapeutic proteins, and other large molecule drugs, we create, develop, and commercialize subcutaneous biologic therapies in collaboration with strategic partners. We believe a patient-centered healthcare approach can lead to a healthier world. We are … Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 2 | 0 | 2 | 91 | |
Alternative Plants Cellular farmers using biotechnology to unlock the full potential of botanical resources. A biotech company dedicated to production of cosmetic ingredients from plant stem cells. We focus on cell cultures of endangered Nordic plants thus using plant biotechnology to make inaccessible treasures accessible. The value we provide is not only a new ingredient - our routine is scrupulous chemical characterisation and efficacy testing to deliver excellent ingredients along with a set of ready-to-use efficacy claims. Cosmetic ingredients, Plant derived active ingredients, In vitro efficacy testing, Anti-ageing ingredients, Skin whitening ingredients, Antioxidants, Plant cell culture, Organic ingredients, and Efficacy claiming Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 4 | 2 | 2 | 9 | |
ProXentia Bioanalysis in a new light ProXentia produces innovative analysis systems for safety and quality monitoring in the food supply chain. ProXentia’s device allows rapid analysis of raw materials entering and leaving the company. Because of its simplicity, the tests can be performed directly in the production or storage site, for more effective control and greater safety. The technology of ProXentia exploits light as a probing tool. The PRX device is indeed based on the proprietary RPI (Reflective Phantom Interface) technology, which exploits the light reflection of innovative materials and allows to perform rapid multiparametric diagnostic tests in a simple way … Tags: H2020 Type: Startup Activities: deeptech biotech healthtech Technologies: New Materials Sensors | 1 | 1 | 0 | 1 | |
Moon Rabbit Through Crypto We Seek Immortality Moon Rabbit is a vertically integrated crypto-meritocratic techno-conglomerate — 安居財閥 (AngoZaibatsu) — constituting a system of systems (Jurisdictions) with the overarching mission of seeking to discover the secret to eternal life — whether biologically or digitally — and to enable humanity to transcend the known dimensions and experience new worlds and spiritual states. blockchain, cryptocurrencies, Ethereum, bitcoin, crypto, dlt, biotech, longevity, polkadot, and web3 Type: NGO, Think-tanks, Ed, & Culture Activities: it services foodtech biotech deeptech healthtech | 17 | 5 | 5 | 5 | |
CimQuest | 2 | 0 | 1 | 3 | |
Aptuit Aptuit, an Evotec company, is a pharmaceutical services provider that offers the most complete set of integrated early discovery to mid-phase drug development solutions by applying scientific excellence, outstanding service and a team of some of the foremost scientific professionals in the industry. These drug discovery and development professionals offer proven experience in key therapeutic areas. They share a legacy of success, having advanced a large number of molecules efficiently, expeditiously and economically, from early discovery through clinical development with low attrition rates. It is our uncommon expertise that allows Aptuit to identify the unexpected, mitigating risks and maximizing promising … Type: Large company Activities: biotech deeptech | 3 | 0 | 3 | 771 | |
Chemetall A global leader of surface treatment technologies The Surface Treatment global business unit of BASF's Coatings division, operating under the Chemetall brand, is a leading supplier of applied surface treatment technologies for metal, plastic, and glass substrates. These specialty chemicals are used in a wide range of industries and end-markets, such as, but not limited to, automotive, aerospace, aluminum finishing, coil, and metal forming, supported by a large network of technical specialists. The portfolio includes solutions for ensuring corrosion protection and coating adhesion, forming and machining of substrates, applications to prepare surfaces for painting processes, and sealants for specific applications … Type: Large company Activities: biotech deeptech | 4 | 1 | 2 | 1,567 | |
GenNext Turf GenNext M3DTM Exoenzymes allow your plants to take on the attributes of the world's most resilient natural grasses Harvested from nature's richest soils, GenNext M3DTM Technology allows your plants to take on the attributes of the world's most resilient natural grasses. We identify and extract over 3,000 specific proteins, hormones, and enzymes – the good stuff – from select microbes found in natural prairie grasses, corn composts, and various turfgrass species. Each of these microbes has a specific function, whether to decompose dead matter to form organic material, to free “tied-up” nutrients from the soil and from dead matter, or … Type: Startup Activities: agritech biotech deeptech Technologies: Bio sourced materials | 0 | 0 | 0 | 2 | |
Pharmtec [Automatic translation follows] Biokill - Decontamination Stations We are the only company on the market specializing in high purity applications at the same time as biosafety applications. We base our know-how on more than 50 years of experience in sterilization in aseptic production, and apply the same strict requirements for biological decontamination of effluents. Pharmtec's patented technology guarantees high resistance to clogging, while offering superior and validatable performances. Aseptic production, Freeze dryer, WFI system, Pure steam generator, GMP and cGMP autoclave, Sterilization and depyrogenation ovens, Isolators, DSVA - H202 decontamination systems, Tofflon, and Pneumatic powder transfer Type: SMB Activities: biotech deeptech industry 4.0 | 0 | 0 | 0 | 11 | |
Rheos Medicines [Automatic translation follows] Rheos Medicines is a biopharmaceutical company harnessing insights in immunometabolism to develop a novel class of medicines with potential to transform the lives of patients with immune mediated diseases. We are rapidly applying a first-in-field approach in immunometabolism with a comprehensive, systems-biology understanding of the metabolic pathways that drive immune cell function and fate coupled to a biomarker discovery effort with potential to bring precision to the treatment of immune-mediated diseases. Launched in 2018 by Third Rock Ventures with a $60 million Series A financing, Rheos is built on groundbreaking science from pioneers in the field, our … Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 1 | 0 | 1 | 23 | |
CID Pharma Packaging [Automatic translation follows] We seek to make life easier for professionals who work in medical laboratories. Boxes of medicines with high quality standards, the best delivery dates, and taking care of the environment. Secondary Packaging for the Pharmaceutical Industry | 0 | 0 | 0 | 22 | |
Zymeworks Inc. Developing novel medicines for patients with difficult-to-treat cancers and other serious diseases. Zymeworks is a global clinical-stage biotechnology company committed to the discovery, development, and commercialization of novel, multifunctional biotherapeutics. Zymeworks’ mission is to make a meaningful difference in the lives of people impacted by difficult-to-treat cancers and other diseases. The Company’s complementary therapeutic platforms and fully integrated drug development engine provide the flexibility and compatibility to precisely engineer and develop highly differentiated antibody-based therapeutic candidates. Zymeworks engineered and developed zanidatamab, a HER2-targeted bispecific antibody using the Company’s proprietary AzymetricTM technology. Zymeworks has entered into separate agreements with BeiGene, Ltd. … Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology | 12 | 0 | 4 | 307 | |
Cytocybernetics Cytocybernetics specializes in cellular electrophysiology. We developed the Cybercyte, which is a very powerful, but user friendly, plug and play dynamic clamp system. We offer a complete range of CRO services, including FDA mandated drug safety screening, custom electrophysiology, custom modelling, and custom analysis. Electrophysiology, Dynamic Clamp, and Drug Safety Screening Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology | 1 | 1 | 0 | 22 | |
Lontra Ventures Lontra Ventures is an Austin, Texas based entrepreneurial consultancy with two core specialties: Life Science Consulting: Specialty Drug Commercialization & Selling Value Added Services to Pharmaceutical Manufacturers Technology: Business Development & Strategic Sales for High-Growth Companies Type: SMB Activities: biotech consulting Technologies: Synthetic Biology | 11 | 0 | 11 | 3 | |
DiscoveryOrtho Partners A Technology Development and Advisory Company Focused on Medical Devices/Biologics Strategic Advisory Services for both large & small medical device/biologics companies including acquisition, licensing, distribution, joint venture agreements Market, Scientific and Clinical Due Diligence Services Business development Services for venture capital, private equity, hedge funds and investment banking clients & their portfolio companies and clients Product/Device development Strategic Product Postioning including licensing, distribtution and market positioning New Company Formation Type: SMB Activities: biotech deeptech healthtech Technologies: Synthetic Biology | 0 | 0 | 0 | 2 | |
Dubai Science Park Founded in 2005, Dubai Science Park (DSP) is a vibrant, holistic, science-focused community, dedicated to supporting entrepreneurs, SMEs and MNEs. Since its inception, the community has grown to more than 350 companies, employing over 3,600 professionals in the life-sciences, energy and environmental sectors. Designed specifically for the needs of businesses and professionals who work in sciences, DSP fosters an environment that supports scientific research, creativity and innovation. By providing ample office and laboratory space, a robust infrastructure and a vibrant community for residents, DSP ensures a supportive ecosystem for residents, businesses and professionals to flourish. Dubai Science Park aims to … Type: NGO, Think-tanks, Ed, & Culture Activities: deeptech biotech | 4 | 2 | 2 | 12 | |
Qnami Unlocking quantum technology to enable a better world. At Qnami we develop fundamental new technology using quantum mechanics. The control and measurement of the state of a single electron enables us to measure what could never be measured before. We call this quantum sensing and we are enthusiastically developing this technique to improve people’s lives and the world. Quantum technologies, Quantum sensing, Metrology, Advanced materials, Scanning NV Microscopy, NV magnetometry, Diamonds, Microfabrication, Quantum engineering, Software, Microscopy, Magnetic Imaging, Material Characterization, and Nanotechnology Type: SMB Activities: biotech deeptech Technologies: New Materials | 11 | 3 | 7 | 20 | |
VAINCRE LE CANCER - NRB [Automatic translation follows] Created in 1987 by Professor Claude JASMIN, Oncologist and Researcher, VAINCRE LE CANCER – NRB is a general interest association whose exclusive goal is Scientific and medical Research in the field of the fight against Cancer and leukemia. Thanks to donations, we actively finance the clinical and fundamental research teams of the cancerology site of the Paul Brousse hospital, the research projects of the medical oncology department of Professor SPANO at the La Pitié Salpêtrière hospital, the CiTHERA cell and gene therapy laboratory. Our objectives are: - Develop studies and research on Cancer and leukemia, following the … Type: NGO, Think-tanks, Ed, & Culture Activities: biotech deeptech | 2 | 1 | 0 | 8 | |
SAINTE CATHERINE, INSTITUT DU CANCER AVIGNON-PROVENCE [Automatic translation follows] Medical institution specializing in the screening and treatment of cancerous tumors. Founded in 1946, the Sainte-Catherine Institute is a medical institution specializing in the screening and treatment of cancerous tumors. Through its recruitment, its technical platform and its clinical research activities, the Sainte Catherine Institute is ranked as one of the most efficient centers in this specialty at the national level. | 3 | 2 | 1 | 198 | |
AXIOS Senolytics [Automatic translation follows] Innovation at the service of your health and well-being. Pharmaceutical company, oriented R&D dedicated to the development and marketing of senolytic compounds, food supplements and drugs against aging, age-related degenerative diseases and cancer. Type: SMB Activities: deeptech biotech healthtech Technologies: Synthetic Biology | 1 | 1 | 0 | N/A | |
Akrivis Mission-critical air cooling and cleaning with a low carbon footprint. Akrivis solutions cool equipment and deliver cleanroom conditions in modular buildings and cabins. Specialist units delivering exceptional performance, outstanding reliability, and ultra-low energy usage. Type: Startup Activities: biotech deeptech Technologies: Decarbonization | 3 | 1 | 2 | 15 | |
Mekonos Inc. Building the future of cell therapies on a chip. Mekonos is a Silicon Valley Venture-backed Life Sciences company — creating a proprietary cell-engineering platform based on scalable silicon technology for our partners engaged in cell & gene therapies and cell line development. Chipset, Gene Therapies, Drug Development, Genetic Diseases, Oncology, Semiconductor, MEMS, Microfluidics, Rare diseases, and Silicon Type: Startup Activities: biotech deeptech nanotech Technologies: Semiconductors | 2 | 0 | 2 | 19 | |
Pear Therapeutics The leader in Prescription Digital Therapeutics Pear Therapeutics, Inc., which is traded on Nasdaq as PEAR, is the parent company of Pear Therapeutics (US), Inc. Pear is the leader in developing and commercializing software-based medicines, called prescription digital therapeutics (PDTs). Pear aims to redefine care through the widespread use of clinically validated software-based therapeutics to provide better outcomes for patients, smarter engagement and tracking tools for clinicians, and cost-effective solutions for payers. Pear has the first end-to-end platform to discover, develop, and deliver PDTs to patients and a pipeline of products and product candidates across therapeutic areas, including the first … Type: Startup Activities: deeptech healthtech biotech Technologies: Synthetic Biology | 15 | 4 | 2 | 36 | |
Editas Medicine What If You Could Repair Broken Genes? What if you could repair broken genes? That is the question we ask ourselves every day at Editas Medicine. We’re a clinical stage genome editing company focused on translating the power and potential of the CRISPR/Cas9 and CRISPR/Cas12a genome editing systems into a robust pipeline of treatments for people living with serious diseases around the world. Our goal is to discover, develop, manufacture, and commercialize transformative, durable, precision genomic medicines for a broad class of diseases. We are a vibrant company full of hope, possibilities, and a belief that, working together as One … Type: Startup Activities: biotech deeptech manufacturing Technologies: Synthetic Biology | 8 | 0 | 2 | 338 | |
Medical Informatics Corp. Transform your health system with comprehensive data Medical Informatics Corp. (MIC) is setting a new standard of care founded on improved patient monitoring, real-time predictive analytics, and patient-centered healthcare. We empower every member of the medical team to improve patient care, expedite intervention, reduce risk, and help create financially strong hospitals by enabling more informed, data-driven decisions. Our SickbayTM️ clinical surveillance and analytics platform features a vendor-neutral Time Series Data Engine (TSDE)TM️ and is cleared as a Class II medical device for patient monitoring, analytics, and alarm distribution. Using Sickbay, physicians, researchers and other members of the care team can … Type: Startup Activities: healthtech biotech deeptech Technologies: Data Analytics | 13 | 1 | 13 | 90 |